By Leah Douglas WASHINGTON, April 17 (Reuters) - Weight-loss drugs may eventually reach only about 50% of the overweight and obese people who could benefit from them due to complexities of healthcare systems and financial constraints,

April 16 () - Eli Lilly said on Thursday its newly approved obesity ‌pill helped reduce the risk ‌of major cardiovascular events at a similar rate ​as insulin glargine in adults with type 2 diabetes and obesity,

Indian drug regulators seized more than 500 suspected counterfeit pens of Eli Lilly's obesity and diabetes drug Mounjaro and said ‌the main accused had ordered raw materials from